Liz Imhoff

Elizabeth received her bachelor's degree in Biological Sciences and Statistics from the University of Pittsburgh in 2023. She then completed a master's degree in Computational Biology and Quantitative Genetics from Harvard T.H. Chan in 2025. During the program, she completed a thesis project with the Udler Lab at the Broad where she researched the utility of a gene expression connectivity map to discover novel therapies for monogenic diabetes. In her most recent role with the Leshchiner Lab at Boston University, she analyzed cancer genomics data from individuals with CLL. Elizabeth is currently an Associate Computational Biologist with the Park Lab.